Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folic Acid for Homocysteine and cIMT in Kidney Transplant
NCT00570856Phase 4Terminated
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 4, randomised, double-blind trial in hyperhomocysteinemia comparing Folic acid with Placebo (2 arms). Primary endpoint: plasma level of total homocysteine at 6 months. Started Jun 2005; status: terminated.
02
Drugs
folic acid
03
Conditions
hyperhomocysteinemia
Beyond the preview
Go deeper on NCT00570856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00570856.